All posts by: Michael Zand

About Michael Zand

The Big Deal About Stem Cell Therapies and Regenerative Medicine – PR Newswire (press release)

Continue reading

2017-07-28 NEWS

The Big Deal About Stem Cell Therapies and Regenerative Medicine
PR Newswire (press release)
Stem cell therapies are a key component of the regenerative medicine field that promises to be a revolutionary approach to treating many degenerative conditions by repairing damaged tissue and harnessing the body’s ability to heal itself. Biotech

Continue reading

2017-07-28 NEWS

R & D Magazine

Stem Cell Therapy Attacks Cancer by Targeting Unique Tissue Stiffness
R & D Magazine
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a more localized way. Weian Zhao …

and more »

Continue reading

2017-07-28 NEWS

Phys.Org

Ancient biology meets modern ingenuity
Phys.Org
Lanzatech’s director of synthetic biology Dr Michael Koepke said the model allowed scientists to predict what happened if certain genes were removed or overexpressed, or if an entirely new pathway was introduced. “This opens the door to establishing …

Continue reading

2017-07-28 NEWS

Bio Roundup: GOP Vote-a-Rama, Immunotherapy Setbacks, Pharma Revamps
Xconomy
Two failed cancer studies this week provided a fresh reminder how little researchers and clinicians understand about immunotherapy’s vagaries: why it works for some people and not for others. The results, in lung cancer and head-and neck cancer, add to …

Continue reading

2017-07-28 NEWS

Bio Roundup: GOP Vote-a-Rama, Immunotherapy Setbacks, Pharma Revamps
Xconomy
Two failed cancer studies this week provided a fresh reminder how little researchers and clinicians understand about immunotherapy’s vagaries: why it works for some people and not for others. The results, in lung cancer and head-and neck cancer, add to …